Becton Dickinson Acquires C.R. Bard for USD 24 Billion

Global medical technology company Becton Dickinson has entered into a definitive agreement to acquire C. R. Bard, Inc., a manufacturer and marketer of medical technologies in the fields of vascular, urology, oncology and surgical specialty products, for a total consideration of USD 24 billion.

Siemens Healthineers

Latest Business News